These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34559985)

  • 21. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
    Bhardwaj N; Heise MT; Ross TM
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e725. PubMed ID: 20582312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
    Walters AW; Kujawa MR; Albe JR; Reed DS; Klimstra WB; Hartman AL
    Virology; 2019 Jan; 526():173-179. PubMed ID: 30396029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate.
    Boyles DA; Schwarz MM; Albe JR; McMillen CM; O'Malley KJ; Reed DS; Hartman AL
    J Gen Virol; 2021 Feb; 102(2):. PubMed ID: 33231535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
    Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine immunoglobulin F(ab')
    Zhao Y; Zheng X; He S; Li Y; Wang W; Gai W; Wong G; Wang H; Yan F; Xue F; Feng N; Wang T; Gao Y; Yang S; Qiu X; Xia X
    Int Immunopharmacol; 2018 Nov; 64():217-222. PubMed ID: 30199846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.
    Dodd KA; McElroy AK; Jones TL; Zaki SR; Nichol ST; Spiropoulou CF
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2874. PubMed ID: 24922480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses.
    Chapman NS; Hulswit RJG; Westover JLB; Stass R; Paesen GC; Binshtein E; Reidy JX; Engdahl TB; Handal LS; Flores A; Gowen BB; Bowden TA; Crowe JE
    Nat Commun; 2023 Sep; 14(1):5650. PubMed ID: 37704627
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ma J; Chen R; Huang W; Nie J; Liu Q; Wang Y; Yang X
    Hum Vaccin Immunother; 2019; 15(10):2286-2294. PubMed ID: 31170027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
    Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
    Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
    Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection.
    Riblett AM; Blomen VA; Jae LT; Altamura LA; Doms RW; Brummelkamp TR; Wojcechowskyj JA
    J Virol; 2016 Feb; 90(3):1414-23. PubMed ID: 26581979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus.
    Allen ER; Krumm SA; Raghwani J; Halldorsson S; Elliott A; Graham VA; Koudriakova E; Harlos K; Wright D; Warimwe GM; Brennan B; Huiskonen JT; Dowall SD; Elliott RM; Pybus OG; Burton DR; Hewson R; Doores KJ; Bowden TA
    Cell Rep; 2018 Dec; 25(13):3750-3758.e4. PubMed ID: 30590046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
    Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
    Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.
    Harmon B; Bird SW; Schudel BR; Hatch AV; Rasley A; Negrete OA
    J Virol; 2016 Aug; 90(16):7084-7097. PubMed ID: 27226375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel indirect ELISA based on glycoprotein Gn for the detection of IgG antibodies against Rift Valley fever virus in small ruminants.
    Jäckel S; Eiden M; Balkema-Buschmann A; Ziller M; van Vuren PJ; Paweska JT; Groschup MH
    Res Vet Sci; 2013 Oct; 95(2):725-30. PubMed ID: 23664015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
    Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lesions and Cellular Tropism of Natural Rift Valley Fever Virus Infection in Young Lambs.
    Odendaal L; Davis AS; Fosgate GT; Clift SJ
    Vet Pathol; 2020 Jan; 57(1):66-81. PubMed ID: 31842723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making Rift Valley Fever Viral Particles Fluorescent.
    Gu Y; Koch J; Garnier C; Erny A; Lozach PY
    Methods Mol Biol; 2024; 2824():165-188. PubMed ID: 39039413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.